BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 4127183)

  • 1. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972.
    Stiver HG; Graves P; Eickhoff TC; Meiklejohn G
    N Engl J Med; 1973 Dec; 289(24):1267-71. PubMed ID: 4127183
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Inactivated influenza vaccines.
    Dowdle WR
    N Engl J Med; 1973 Dec; 289(24):1309-10. PubMed ID: 4127184
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural history of influenza type A in the United States, 1957-1972.
    Dowdle WR; Coleman MT; Gregg MB
    Prog Med Virol; 1974; 17(0):91-135. PubMed ID: 4608959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the immunity against influenza in the population of Milan in the fall of 1972. Distribution of h.i.a. (hemagglutination inhibition antibodies) against A-Hong Kong-68 and A-England-42-72 viruses and the immunizing effectiveness of current vaccines].
    Profeta ML; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(1):25-31. PubMed ID: 4714450
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual features of the 1971 influenza epidemic in Hungary and the antigen analysis of the isolates by a serum adsorption test.
    Barb K; Takátsy G
    Bull World Health Organ; 1973; 49(1):21-4. PubMed ID: 4545152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influenza in Kabul 1968-69 due to influenza virus A2 Hong Kong-68. A contribution to influenza surveillance in Afghanistan].
    Thraenhart O; Sery V; Habib A; Amin F
    Zentralbl Bakteriol Orig A; 1971 Oct; 218(2):160-7. PubMed ID: 4403536
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the viruses of Asiatic influenza. VII. Hong Kong influenza.
    Lobodzińska M; Wlodarczyk J; Sworeń R; Iwańczak F; Kidankiewicz T; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1970; 18(1):1-11. PubMed ID: 5438563
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses.
    Aymard M; Bentejac MC; Larbaigt G; Michaut D; Triau R
    Dev Biol Stand; 1979; 43():231-9. PubMed ID: 520670
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemic of Hong-Kong A2 influenza in Yugoslavia].
    Vodopija I
    Lijec Vjesn; 1969; 91(12):1316-9. PubMed ID: 4913908
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain.
    Hoskins TW; Davies JR; Allchin A; Miller CL; Pollock TM
    Lancet; 1973 Jul; 2(7821):116-20. PubMed ID: 4124042
    [No Abstract]   [Full Text] [Related]  

  • 12. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic use of amantadine during Hong Kong influenza epidemic.
    Máté J; Simon M; Juvancz I; Takátsy G; Hollós I; Farkas E
    Acta Microbiol Acad Sci Hung; 1970; 17(3):285-96. PubMed ID: 5534106
    [No Abstract]   [Full Text] [Related]  

  • 14. [Classification of A2 Hong Kong virus isolated in the course of influenza epidemic and its antigenic affinity with other influenza viruses of type A].
    Colonnello F; Signorini C
    G Mal Infett Parassit; 1970 Sep; 22(9):624-7. PubMed ID: 4935842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 16. Influenza and influenza vaccination.
    Goodman RA; Hinman AR; Nolan TF; Brandling-Bennett AD
    Am Fam Physician; 1980 Jan; 21(1):101-5. PubMed ID: 7350730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza.
    Schoenbaum SC; Gregg MB
    J Infect Dis; 1969 Jan; 119(1):102-4. PubMed ID: 5774118
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.